Loading ...

PEGylated doxorubicin-loaded benzaldehyde-functionalized mesoporous silica nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

1

benzaldehyde-functionalized mesoporous silica nanoparticles

benzaldehyde-functionalized MCM-41 MSN-CHO
Type Nano Material
Formula
Role core
2

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role layer
3

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role layer
4

methoxy-(polyethylene glycol)-amine

MeO-PEG-NH2
Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release dependent on pH

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
  1. pWXC
  2. HSzlI
  3. wWj8
  4. wYVe
  5. stVQGI8y
Product

PEGylated doxorubicin-loaded benzaldehyde-functionalized mesoporous silica nanoparticles

Pore size: ~ 1.95 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial